Keyphrases
Finland
100%
Type 1 Diabetes Mellitus (T1DM)
97%
Type I Diabetes
96%
Confidence Interval
90%
Islet Autoimmunity
76%
Randomized Controlled Trial
73%
Uganda
69%
Human Adipose-derived Stem Cells (hADSCs)
46%
Low Birth Weight
45%
Diabetes
43%
Lipid Supplementation
40%
High Risk
40%
Older children
38%
Type 2 Diabetes Mellitus (T2DM)
36%
Severe Malnutrition
36%
Celiac Disease
36%
Transient Receptor Potential Vanilloid 1 (TRPV1)
34%
Clinical Trials
33%
Ready-to-use Therapeutic Food
33%
Prospective Cohort Study
32%
Population-based Study
31%
Bioactive Glass
30%
Odds Ratio
30%
Malawi
30%
Meta-analysis
30%
Etiology
29%
Hazard Ratio
29%
Inflammation
29%
Stunted children
28%
Antenatal Intervention
27%
University Hospital
27%
Small-for-gestational Age
27%
Single Center
27%
DNA Methylation (DNAm)
27%
Environmental Determinants
27%
Obesity
26%
In Vitro Biocompatibility
26%
Rural Malawi
26%
Hip Fracture
26%
Bioactive Glass Scaffolds
26%
Rheumatic Diseases
26%
Mid-upper Arm Circumference
26%
Low-middle Income Countries
25%
Tampere
25%
Body Composition
25%
Older Adults
23%
Cell Culture
23%
Risk Factors
23%
Vegetables
22%
Kenya
21%
Young Finns Study
21%
Body Mass Index
21%
Dietary Intake
21%
Linear Growth
21%
Gluten
21%
Overall Survival
21%
Physical Activity
20%
During Pregnancy
20%
Autoantibodies
20%
Azithromycin
20%
Milk Protein
20%
Child Growth
20%
Micronutrient Status
20%
Weight-for-age z Score
20%
Pregnant Women
20%
Height-for-age Z-score
20%
Anxiety-depression
19%
Prostate Cancer
19%
High-risk Human Papillomavirus (HR-HPV)
19%
Prognostic Factors
19%
Cognitive Performance
19%
Urinary Incontinence
19%
Bone Regeneration
19%
Tissue Engineering
19%
Whey Permeate
19%
Fasting Plasma Glucose
19%
Preterm Birth
19%
Mali
18%
Stem Cell-derived
18%
Myopathy
18%
Depressive Symptoms
18%
Tanzania
18%
Psychosocial Support
18%
Retrospective Cohort Study
18%
Stillbirth
17%
Bacteremia
17%
Human Mesenchymal Stem Cells (hMSCs)
17%
Randomized Placebo-controlled Trial
17%
Borosilicate Bioactive Glass
17%
In Vitro Dissolution
17%
Corneal Stroma
17%
CpG Sites
17%
Milk Whey
17%
Developmental Dysplasia of the Hip
17%
Factorial Trial
17%
Induced Pluripotent Stem Cells (iPSCs)
17%
Scleroderma
17%
Older Women
17%
Physical Performance
17%
Cluster Randomized Trial
17%
Medicine and Dentistry
Randomized Controlled Trial
63%
Neonatal Infant
55%
Systematic Review
53%
Arm
52%
Insulin Dependent Diabetes Mellitus
47%
Diseases
46%
Autoimmunity
43%
Adipose Tissue
37%
Stem Cell
36%
Cohort Analysis
33%
Prevalence
33%
Low Birth Weight
33%
Meta-Analysis
32%
Tissue Regeneration
32%
Malignant Neoplasm
31%
Diabetes
31%
Health Care Cost
29%
Blood Pressure
28%
Maturity Onset Diabetes of the Young
28%
In Vitro
27%
Wart Virus
26%
Hip Fracture
26%
Retrospective Cohort Study
26%
Prospective Cohort Study
24%
Odds Ratio
23%
Induced Pluripotent Stem Cell
23%
Clinical Trial
22%
Pulse Wave Velocity
22%
Physical Activity
22%
Low and Middle Income Countries
22%
Prostate Cancer
21%
Small for Gestational Age
21%
Placebo
20%
Infection
20%
Offspring
19%
Hemodynamic
19%
Coronary Artery Disease
19%
Stromal Cell
18%
Premature Labor
18%
Overall Survival
17%
Azithromycin
17%
Drug Administration
17%
Dysplasia
17%
Streptococcus Dysgalactiae
17%
Prognostic Factor
17%
Hepatocyte
17%
Stroma of Cornea
17%
Ascorbic Acid 2 Phosphate
17%
Alzheimer's Disease
17%
Bloodstream Infection
17%
Drug Response
17%
Systemic Vascular Resistance
17%
Autoantibodies
17%
Quality of Life
17%
Urine Incontinence
16%
Enuresis
16%
Cancer
16%
Cardiovascular System
15%
Surgery
14%
Cell Culture
14%
Supplementation
14%
Body Mass Index
14%
Stunting
13%
Nutrition
13%
Splinting
13%
Heart Work
13%
Osteoarthritis
12%
Observational Study
12%
Cross Sectional Study
12%
Stillbirth
12%
T-Helper Cell
12%
Malnutrition
12%
Gestational Diabetes
11%
Urinary System
11%
Pre-Eclampsia
11%
Disease Severity
11%
Obesity
11%
Lipid Metabolism
11%
Biological Marker
11%
Hazard Ratio
11%
Birth Outcomes
11%
Diagnosis
11%
Autoimmune Disease
11%
Biocompatible Material
11%
Secondary Data
11%
Gestational Age
10%
Outpatient
10%
Labor Onset
10%
Lactation
10%
Primary Hyperaldosteronism
10%
Symptomatic Treatment
10%
Oncology
10%
Interleukin 6
10%
Medical Record
10%
Seasonal Variation
10%
Case-Control Study
10%
Body Position
10%
Genetic Risk
10%
Low Back Pain
10%
Neoplasm
9%